The Impact of CBT for Insomnia on Alcohol Treatment Outcomes among Veterans

CBT 治疗失眠对退伍军人酒精治疗结果的影响

基本信息

  • 批准号:
    9753816
  • 负责人:
  • 金额:
    $ 18.22万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2018
  • 资助国家:
    美国
  • 起止时间:
    2018-08-01 至 2022-07-31
  • 项目状态:
    已结题

项目摘要

PROJECT SUMMARY / ABSTRACT Alcohol use disorders (AUDs) are prevalent among Veterans and result in significant physical and psychological burden. Among those who receive treatment for AUDs, 1 in 3 relapses to problematic drinking within one year of treatment. Thus, additional strategies are needed to enhance alcohol treatment outcomes. One promising approach involves providing concurrent treatment for a common complaint – difficulty falling or staying asleep. As many as 63% of Veterans with AUDs report co-occurring symptoms of insomnia. Given the negative impact of insomnia on attention and emotion regulation, insomnia symptoms may decrease patients’ abilities to attend to alcohol treatment and manage negative emotions that lead to craving and relapse. Moreover, approximately 50% of individuals with AUDs report using alcohol to help them sleep, making relapse more likely for those with no other tools or skills to help them sleep. Indeed, sleep disturbance has been identified as a risk factor for relapse among individuals in alcohol treatment. Thus, effective treatment of sleep problems may enhance alcohol treatment for a substantial number of individuals with AUDs. Cognitive Behavioral Therapy for Insomnia (CBTi) has been effective in reducing insomnia severity in individuals with AUDs; however, no investigations have examined the efficacy of CBTi delivered concurrently with AUD treatment to determine its impact on treatment engagement. This R21 aims to examine the feasibility, acceptability, and initial efficacy of a CBTi supplement to ongoing outpatient alcohol treatment at the VA. We will conduct a randomized pilot trial with 80 Veterans who meet DSM-5 criteria for AUD and the episodic criterion for Insomnia Disorder. Participants will be randomly assigned to a minimal-treatment (education) control involving sleep hygiene education in addition to treatment as usual (eTAU; n = 40) or TAU+CBTi (n = 40). Outcomes will be assessed at the end of the active intervention period (6 weeks) and 6 weeks post- intervention. Outcomes of interest include recruitment and retention rates, treatment satisfaction, percentage of abstinent days, percentage of heavy drinking days, alcohol-related consequences, use of alcohol as a sleep aid, sleep efficiency, ability to sustain attention, working memory, negative affect, and emotion regulation. Data analyses will focus on size of treatment effects. Results will inform an R01 application to examine the efficacy, cost-effectiveness, and potential mechanisms of CBTi in preventing or delaying relapse to problematic drinking among Veterans with insomnia and AUDs. This study will provide initial evidence that treatment of insomnia not only improves sleep but also allows participants to derive greater benefit from intensive outpatient alcohol treatment.
项目摘要 /摘要 饮酒障碍(AUD)在退伍军人中普遍存在,并导致重要的物理 心理负担。 在提升的一年内,这里的其他策略可以增强酒精治疗结果。 一种有前途的方法涉及提供并发的信任 在有63%的退伍军人中,有63%的退伍军人报告了失眠的症状 失眠对注意力和情绪调节的负面影响,失眠症状可能会降低患者 接受酒精治疗并管理导致渴望和复发的负面情绪的能力。 此外,大约50%的酒精患者可以帮助他们入睡 对于那些没有其他工具或技能的人来说,更有可能帮助他们睡眠障碍。 被确定为在酒精治疗中个人复发的危险因素。 问题可能会增强大量aud的人的酒精治疗 失眠(CBTI)的行为疗法已有效减少失眠严重程度 但是,没有投资检查CBTI的功效 确定其对治疗参与的影响。 CBTI补充剂在VA中对饮酒的可接受性和初始功效 将与80名符合DSM-5 AUD标准的退伍军人进行随机试验试验 失眠症的标准将随机分配给最小的治疗(教育) 控制相关睡眠卫生教育除了往常(etau; n = 40)或tau+cbti(n = 40)将在主动干预期结束时进行评估(6周) 干涉。 节制的日子,大量饮酒日的百分比,与酒精相关的共和国,将酒精用作啤酒 援助,睡眠效率,维持及格的能力,工作记忆,负面影响和情绪调节。 分析将集中于治疗效果的大小。 成本效益和CBTI生产中CBTI的潜在机制或延迟饮酒的复发 在失眠和auds的退伍军人中。 不仅可以改善睡眠 治疗。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JOHN E MCGEARY其他文献

JOHN E MCGEARY的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JOHN E MCGEARY', 18)}}的其他基金

sTMS for Substance Use-disordered Veterans
针对药物使用障碍退伍军人的 sTMS
  • 批准号:
    10006926
  • 财政年份:
    2020
  • 资助金额:
    $ 18.22万
  • 项目类别:
sTMS for Substance Use-disordered Veterans
针对药物使用障碍退伍军人的 sTMS
  • 批准号:
    10427191
  • 财政年份:
    2020
  • 资助金额:
    $ 18.22万
  • 项目类别:
sTMS for Substance Use-disordered Veterans
针对药物使用障碍退伍军人的 sTMS
  • 批准号:
    10663804
  • 财政年份:
    2020
  • 资助金额:
    $ 18.22万
  • 项目类别:
sTMS for Substance Use-disordered Veterans
针对药物使用障碍退伍军人的 sTMS
  • 批准号:
    10159126
  • 财政年份:
    2020
  • 资助金额:
    $ 18.22万
  • 项目类别:
Brown University Shared DNA Sequencer
布朗大学共享 DNA 测序仪
  • 批准号:
    7389065
  • 财政年份:
    2008
  • 资助金额:
    $ 18.22万
  • 项目类别:
STRESS INDUCED INCREASES IN ALCOHOL EFFECTS
压力引起的酒精效应增加
  • 批准号:
    6509119
  • 财政年份:
    2002
  • 资助金额:
    $ 18.22万
  • 项目类别:
STRESS INDUCED INCREASES IN ALCOHOL EFFECTS
压力引起的酒精效应增加
  • 批准号:
    6371276
  • 财政年份:
    2001
  • 资助金额:
    $ 18.22万
  • 项目类别:
STRESS INDUCED INCREASES IN ALCOHOL EFFECTS
压力引起的酒精效应增加
  • 批准号:
    6062448
  • 财政年份:
    2000
  • 资助金额:
    $ 18.22万
  • 项目类别:

相似国自然基金

分子生物学联合CT血管成像研究不同种类酒及饮酒量对猪血管弹性的作用机制
  • 批准号:
    81371548
  • 批准年份:
    2013
  • 资助金额:
    75.0 万元
  • 项目类别:
    面上项目

相似海外基金

RNA biomarkers for alcohol use disorder
酒精使用障碍的 RNA 生物标志物
  • 批准号:
    10808532
  • 财政年份:
    2023
  • 资助金额:
    $ 18.22万
  • 项目类别:
StuDy AimED at Increasing AlCohol AbsTinEnce (DEDICATE)
旨在提高酒精戒断率的研究(奉献)
  • 批准号:
    10577022
  • 财政年份:
    2023
  • 资助金额:
    $ 18.22万
  • 项目类别:
Combination Therapeutic for Chronic Opioid Use Disorder Relapse
慢性阿片类药物使用障碍复发的联合治疗
  • 批准号:
    10706844
  • 财政年份:
    2023
  • 资助金额:
    $ 18.22万
  • 项目类别:
Pregnenolone for the Treatment of Alcohol Use Disorder
孕烯醇酮用于治疗酒精使用障碍
  • 批准号:
    10681961
  • 财政年份:
    2023
  • 资助金额:
    $ 18.22万
  • 项目类别:
Avoidance learning and pain circuit dysfunction in alcohol use disorders
酒精使用障碍中的回避学习和疼痛回路功能障碍
  • 批准号:
    10349780
  • 财政年份:
    2022
  • 资助金额:
    $ 18.22万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了